PP
AUPH icon

PDT Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

PDT Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.93M Hold
265,491
– – 0.23% 144
2025
Q4 		$4.23M Hold
265,491
– – 0.27% 131
2025
Q3 		$2.93M Sell
265,491
-63,210
-19% -$690K 0.19% 191
2025
Q2 		$2.78M Buy
328,701
+14,182
+5% +$114K 0.16% 224
2025
Q1 		$2.53M Buy
314,519
+12,966
+4% +$105K 0.18% 193
2024
Q4 		$2.71M Hold
301,553
– – 0.24% 142
2024
Q3 		$2.21M Buy
301,553
+130,204
+76% +$807K 0.2% 184
2024
Q2 		$978K Buy
+171,349
New +$902K 0.09% 336
2022
Q2 		– Sell
-69,917
Closed -$866K – 952
2022
Q1 		$866K Buy
+69,917
New +$1.08M 0.07% 418

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return